Skip to main content
Tech.euFundingExplorerBeta

Signals

Funding-only, explainable estimates from the data — not predictions, and not investment advice. Each score shows its base rate and the factors behind it.

Base rates (this dataset): a round is followed by another 38% of the time · 11.3% of companies with 2+ rounds have exited · snapshot as of 2026-11-13
Methodology →

Tech.eu Heat 50

Healthtech · top 50
#CompanyStageLast roundTimingRaise nextHeat
1Neko Health
Healthtech · Sweden
Series C2026-07just raised · ▲3597
2Breye Therapeutics
Healthtech · Denmark
Series A2026-10just raised · ▲2094
3CMR Surgical
Healthtech · UK
Growth/Late2026-10just raised · ▲1693
4HighLife
Healthtech · France
Other2026-09just raised · ▲1592
5OMass Therapeutics
Healthtech · UK
Series C2026-10just raised · ▲2191
6Nouscom
Healthtech · Switzerland
Series B2026-10just raised · ▲2091
7IMU Biosciences
Healthtech · UK
Other2026-06just raised · ▲2691
8Ingenix
Healthtech · Poland
Seed2026-06just raised · ▲4390
9Leyden Labs
Healthtech · Netherlands
Other2026-06just raised · ▲2389
10Anaconda Biomed
Healthtech · Spain
Other2026-09just raised · ▲1589
11Optics11
Healthtech · Netherlands
Other2026-11just raised · ▲1288
12Yazen
Healthtech · Sweden
Other2026-10just raised · ▲1388
13Adaptyv Biosystems
Healthtech · Switzerland
Series A2026-08just raised · ▲2488
14Uromems
Healthtech · France
Growth/Late2026-05just raised · ▲3387
15Ona Therapeutics
Healthtech · Spain
Series B2026-06just raised · ▲3887
16Sensible Biotechnologies
Healthtech · UK
Other2026-10just raised · ▲1487
17Ethris
Healthtech · Germany
Other2026-09just raised · ▲1685
18Biolevate
Healthtech · France
Series A2026-09just raised · ▲2185
19Orakl Oncology
Healthtech · France
Series A2026-11just raised · ▲1784
20Xeltis
Healthtech · Switzerland
Other2026-07just raised · ▲2083
21Isomorphic Labs
Healthtech · UK
Series B2026-05just raised · ▲4582
22FoRx Therapeutics
Healthtech · Switzerland
Series A2025-12in window · ▲5682
23TidalSense
Healthtech · UK
Other2026-07just raised · ▲2082
24Biorce
Healthtech · Spain
Series A2026-02in window · ▲5181
25Biograil
Healthtech · Denmark
Other2026-11just raised · ▲1181
26Imperagen
Healthtech · UK
Seed2026-05just raised · ▲4281
27Basecamp Research
Healthtech · UK
Series C2026-09just raised · ▲2580
28AnaCardio
Healthtech · Sweden
Series B2026-09just raised · ▲2280
29Implicity
Healthtech · France
Growth/Late2026-09just raised · ▲1980
30Scan.com
Healthtech · UK
Debt2026-09just raised · ▲3579
31Lucis
Healthtech · France
Series A2026-05just raised · ▲3579
32Telum Therapeutics
Healthtech · Spain
Series A2026-07just raised · ▲3179
33Aitiologic
Healthtech · Austria
Seed2026-09just raised · ▲2378
34Grapheal
Healthtech · France
Grant2026-06in window · ▲4978
35Aerska
Healthtech · Ireland
Series A2026-02in window · ▲5077
36Centauri
Healthtech · UK
Series A2026-02in window · ▲4877
37Ahead Health
Healthtech · Switzerland
Other2026-07just raised · ▲2077
38Gosta Labs
Healthtech · Finland
Seed2025-11in window · ▲6777
39Semble
Healthtech · UK
Series C2026-06just raised · ▲4376
40Recare Solutions
Healthtech · Germany
Other2026-01in window · ▲3976
41Gate2Brain
Healthtech · Spain
Other2026-06just raised · ▲2676
42Mironid
Healthtech · UK
Series B2026-08just raised · ▲2975
43Jutro Medical
Healthtech · Poland
Series A2025-12in window · ▲5775
44Aptadir Therapeutics
Healthtech · Italy
Seed2026-09just raised1975
45Rivercell
Healthtech · France
Seed2026-10just raised2075
46tacalyx
Healthtech · Germany
Seed2026-04in window · ▲4675
47SRTD Biotech
Healthtech · Germany
Seed2026-11just raised1474
48Tensive
Healthtech · Italy
Debt2026-09just raised · ▲3574
49AssistMe
Healthtech · Germany
Other2026-08just raised · ▲1874
50Carewell
Healthtech · Switzerland
Seed2026-07just raised · ▲3574

Most likely to raise next

raise-likelihood score

Exit candidates

exit likelihood · 2+ rounds

Scores are model estimates, not facts: a base rate computed from this dataset, adjusted by transparent funding-only factors (timing vs cohort gap, round-size momentum, backer re-investment, firm characteristics). No per-company “unicorn” probability is published. In a back-test (cut-off 30 June 2023, 18-month horizon), companies the model placed in their typical raise window went on to raise again about 1.8× as often as the average tracked company (~14% vs ~8%), while companies flagged dormant raised under 1% of the time. Estimates, not predictions.